Chapter[ X. Review of the Major League Baseball Joint Drug Prevention and
Treatment Program ]
Section[ B. 5. Due Process for Players ]
5. Due Process for Players
Any determination that a player has violated the joint program is subject to review
by a three-member arbitration panel.557 The confidentiality provisions of the program precluded
me from reviewing records of such appeal proceedings. As a result, I have not been able to
553 National Football League Policy on Anabolic Steroids and Related Substances, § 6
554 National Basketball Players Association Collective Bargaining Agreement, Art. 33,
§ 9(c) (1999).
555 Id. at Art. 33, § 12(a).
556 Collective Bargaining Agreement Between National Hockey League and National
Hockey League Players Association, Art. 47, §§ 47.2. and 47.7 (2005).
557 See Major League Baseball’s Joint Drug Treatment and Prevention Program, § 9
assess the operation of those procedures. However, we received no information suggesting that
the rights of players were not adequately protected in the operation of the program.